LESLIE, L. A.; GANGAN, N.; TAN, H.; HUANG, Q.; YAN, J. Clinico-economic burden of first-line chemoimmunotherapy by risk status in chronic lymphocytic leukemia. Journal of Current Medical Research and Opinion, [S. l.], v. 5, n. 05, 2022. Disponível em: https://cmro.in/index.php/jcmro/article/view/520. Acesso em: 22 aug. 2026.